comparisonFebruary 10, 2026The Peptide Catalog

TB-4 vs TB-500: Full Comparison (2026)

TB-4 vs TB-500: full peptide vs synthetic fragment with mechanisms, stability, dosing, and pricing compared.

Live Price Comparison

Prices updated automatically from verified vendors

MetricThymosin Beta-4TB-500
Best Value (per mg)
$6.80/mg
EZ Peptides10mg
$4.40/mg
EZ Peptides10mg
Lowest Price
$68.00
EZ Peptides10mg
$30.00
Penguin Peptides5mg
In-Stock Vendors1 offers7 offers
Available Sizes10mg5mg, 10mg
Full PricingView all pricesView all prices

Parent Peptide vs Active Fragment

Thymosin Beta-4 (TB-4) is the full 43-amino acid endogenous peptide. TB-500 is a synthetic fragment of TB-4 — specifically the 7-amino acid active region (Ac-LKKTETQ, residues 17–23) responsible for actin binding and cell migration signaling.

This is one of the most frequently asked questions in peptide research. They are related but not interchangeable.

For a complete deep dive into TB-4, see our Thymosin Beta-4 Research Guide.

Mechanism Comparison

TB-4 (Full Peptide)

TB-4 is the body's primary actin-sequestering molecule. As the full-length peptide, it activates the complete native signaling cascade:

TB-4 provides the full biological context — some downstream effects may require the complete peptide sequence.

TB-500 (Fragment)

TB-500 contains the core active region of TB-4. It retains the primary mechanism but in a smaller, more stable package:

TB-500 may lack some of TB-4's broader signaling — particularly the full progenitor cell activation cascade — but delivers the core repair signal more efficiently.

Quick Comparison Table

FeatureTB-4 (Thymosin Beta-4)TB-500
Structure43 amino acids (full peptide)7 amino acids (active fragment)
Molecular weight~4,921 Da~843 Da
OriginEndogenous — naturally producedSynthetic — lab-manufactured
StabilityLower (larger molecule)Higher (smaller, more resistant)
Tissue distributionBroad (carried by platelets)Extremely broad (small molecule diffusion)
Core mechanismComplete actin + multi-pathwayTargeted actin-binding & migration
Progenitor cell activationYes (full cascade)Unclear (may be partial)
Anti-fibroticStrong evidenceExtrapolated from TB-4 data
Published researchExtensive (Nature, PNAS, etc.)Limited direct studies
CostHigherLower
Typical dose2–5 mg, 2x/week2–5 mg, 2x/week
🧪

Ready to Buy? Compare Prices

Best current prices from verified vendors with COA testing.

Thymosin Beta-4

EZ Peptides · 10mg · $6.80/mgCOA ✓

$68.00
TB-500

EZ Peptides · 10mg · $4.40/mgCOA ✓

$44.00

Research Applications Compared

Where TB-4 Has Stronger Evidence

Where TB-500 May Have Advantages

Where Both Are Studied

Can You Use Both Together?

Many research protocols explore combining TB-4 and TB-500. The rationale:

This combination attempts to get the best of both — complete biology from TB-4 plus superior tissue reach from TB-500.

Stacking with BPC-157

Both TB-4 and TB-500 are frequently combined with BPC-157, which works through entirely different mechanisms (nitric oxide, growth factors, gut-brain axis). See our BPC-157 vs TB-500 comparison for details.

Dosing Comparison

For research and educational discussion only.

ProtocolTB-4TB-500
Loading4–10 mg/week (divided)4–8 mg/week (divided)
Maintenance2–5 mg/week2–4 mg/week
Frequency2–3x per week2x per week
Duration4–12 weeks4–12 weeks
ReconstitutionBacteriostatic water, store 2–8°CSame

Dosing is similar because TB-500's smaller size is offset by potentially lower per-molecule signaling breadth.

The Bottom Line

If your research focus is...Consider
Cardiac repair / progenitor cellsTB-4 (strongest evidence)
General healing on a budgetTB-500 (better cost/distribution)
Maximum tissue penetrationTB-500 (6x smaller molecule)
Broadest biological effectTB-4 (complete signaling cascade)
Stacking with BPC-157Either (both are complementary)
Longest shelf stabilityTB-500
Both combinedTB-4 + TB-500 (full signal + broad reach)

TB-4 is the more research-backed option with the complete mechanism. TB-500 is the practical, cost-effective option that delivers the core repair signal. Neither is wrong — the choice depends on research priorities and budget.

Related Comparisons & Guides

This article is for educational and research purposes only. It is not medical advice.